About
Wolfgang Link is a CSIC researcher and group leader at the Institute of Biomedical Research Alberto Sols (IIBM) in Madrid, where his work addresses drug resistance mechanisms in cancer and human longevity, with a focus on FOXO transcription factors. He holds academic appointments as honorary professor at the Universidad Autónoma de Madrid and invited assistant professor at the Universidade do Algarve in Faro, Portugal, and is co-founder of Refoxy Pharma GmbH, a biotech company targeting FOXO proteins. Link holds three patents, has published more than 90 articles alongside three books and book chapters, and has contributed to research including the cloning of Arg3.1/ARC and DREAM and the characterization of TRIB2 as an oncogene in melanoma.
Scientific Co-founder & Advisor at Refoxy
Intro paths
In turn, Wolfgang can intro founders to Refoxy's investors below.
Refoxy's investors · 4
Co-founders at Refoxy
Experience
- Institute of Biomedical Research Alberto Sols (IIBM)Group leader at CSIC-IIBmcurrent2018 — presentSpain
- University of Algarve, FaroAssistant Professor2012 — 2023University of Algarve, Gambelas Campus, Building 7, Room 3.17; 8005-139 Faro, P
- Spanish National Cancer Research Centre (CNIO), Madrid, SpainSenior Scientist2001 — 2011Madrid, Spain
- EleGenePhD2000 — 2001
- InstitutoCajalPhD student1996 — 1999
- ZMNHPhD student1994 — 1995
Skills & more
+4 more
Signal TransductionTissue CultureGeneticsCellLanguages English · German · Portuguese · Spanish
From Wolfgang's professional profile.
Frequently asked questions
- Who is Wolfgang Link?
- Wolfgang Link is a CSIC researcher and group leader at the Institute of Biomedical Research Alberto Sols (IIBM) in Madrid, where his work addresses drug resistance mechanisms in cancer and human longevity, with a focus on FOXO transcription factors. He holds academic appointments as honorary professor at the Universidad Autónoma de Madrid and invited assistant professor at the Universidade do Algarve in Faro, Portugal, and is co-founder of Refoxy Pharma GmbH, a biotech company targeting FOXO proteins. Link holds three patents, has published more than 90 articles alongside three books and book chapters, and has contributed to research including the cloning of Arg3.1/ARC and DREAM and the characterization of TRIB2 as an oncogene in melanoma.
- Where does Wolfgang Link work?
- Wolfgang Link is Scientific Co-founder & Advisor of Refoxy.
- What companies did Wolfgang Link found?
- Wolfgang Link founded Refoxy.
- Where did Wolfgang Link go to school?
- Wolfgang Link studied at University of Hamburg, Germany (Diploma & PhD); Wittelsbacher Gymnasium, München, Germany (Abitur).
Are you in our directory? — or find your own page and tap it there to see your paths to every investor.
